{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:48:47Z","timestamp":1786996127407,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011075","name":"David Geffen School of Medicine, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008603","name":"Cancer Institute, University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008603","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012990","name":"Universit\u00e0 degli Studi di Siena","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009455","name":"West Virginia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008529","name":"Chiba University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009874","name":"Universit\u00e9 de Sherbrooke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006418","name":"Brown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008457","name":"University of Virginia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017115","name":"Oakland University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017115","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017064","name":"Rhode Island Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019084","name":"Kobe University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006962","name":"NYU Langone Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015258","name":"Zhejiang\u00a0Provincial\u00a0People's\u00a0Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006954","name":"Tufts Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019311","name":"Northwell Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008246","name":"Tufts University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010249","name":"School of Medicine, Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030622","name":"UNC Department of Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001320","name":"Roswell Park Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","award":["2023-1-20"],"award-info":[{"award-number":["2023-1-20"]}],"id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024217","name":"Osaka International Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008478","name":"Wake Forest School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009076","name":"University of Science and Technology of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.radonc.2026.111449","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T23:05:54Z","timestamp":1771801554000},"page":"111449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor control probability modeling of stereotactic radiosurgery and fractionated stereotactic radiosurgery for patients with brainstem metastases"],"prefix":"10.1016","volume":"218","author":[{"given":"Ji-Wen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Min","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4932-1986","authenticated-orcid":false,"given":"Nicholas G","family":"Zaorsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111449_b0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/CCO.0b013e32831186fe","article-title":"Brain metastases: current management and new developments","volume":"20","author":"Soffietti","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11060-019-03195-y","article-title":"The case for radiosurgery for brainstem metastases","volume":"143","author":"Winograd","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2026.111449_b0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0305-7372(03)00105-1","article-title":"The management of brain metastases","volume":"29","author":"Patchell","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2026.111449_b0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.wneu.2015.10.089","article-title":"How does brainstem involvement affect prognosis in patients with limited brain metastases? results of a matched-cohort analysis","volume":"88","author":"Trifiletti","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.radonc.2026.111449_b0025","doi-asserted-by":"crossref","DOI":"10.1227\/01.NEU.0000325726.72815.22","article-title":"Radiation tolerance limits of the brainstem","volume":"63","author":"Sharma","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2026.111449_b0030","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0035","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report from the AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0040","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ijrobp.2009.08.078","article-title":"Radiation associated brainstem injury","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.radonc.2011.08.041","article-title":"Treatment of brain metastases: review of phase III randomized controlled trials","volume":"102","author":"Scoccianti","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0055","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","article-title":"Treatment of brain metastases","volume":"33","author":"Lin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0060","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijrobp.2008.03.009","article-title":"Memory function before and after whole brain radiotherapy in patients with and without brain metastases","volume":"72","author":"Welzel","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2026.111449_b0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/neuonc\/noae201","article-title":"Stereotactic radiosurgery for 1-10 brain metastases to avoid whole-brain radiotherapy: results of the CYBER-SPACE randomized phase 2 trial","volume":"27","author":"El Shafie","year":"2025","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0075","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2026.111449_b0080","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2026.111449_b0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 Study","volume":"29","author":"Kocher","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0095","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jamaoncol.2021.1262","article-title":"Efficacy and safety of stereotactic radiosurgery for brainstem metastases: a systematic review and meta-analysis","volume":"7","author":"Chen","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijrobp.2016.06.009","article-title":"Stereotactic radiosurgery for brainstem metastases: an international cooperative study to define response and toxicity","volume":"96","author":"Trifiletti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111107","article-title":"Definition and requirements for stereotactic radiotherapy: a systematic review","volume":"211","author":"Kuncman","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0110","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1200\/JCO.2015.61.9569","article-title":"Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer","volume":"33","author":"Goldstein","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamaoncol.2017.4211","article-title":"Estimating cost-effectiveness of a multimodal ovarian cancer screening program in the united states: secondary analysis of the UK collaborative trial of ovarian cancer screening (UKCTOCS)","volume":"4","author":"Moss","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110529","article-title":"Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: a dosimetric pooled analysis of individual patient data","volume":"200","author":"Bai","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2016.11.006","article-title":"Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models","volume":"122","author":"Liu","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijrobp.2019.03.045","article-title":"Local control after stereotactic body radiation therapy for stage i non-small cell lung cancer","volume":"110","author":"Lee","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0135","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2026.111449_b0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0167-8140(83)80021-8","article-title":"A new isoeffect curve for change in dose per fraction","volume":"1","author":"Withers","year":"1983","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0145","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1118\/1.2969065","article-title":"Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation","volume":"35","author":"Astrahan","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijrobp.2020.11.019","article-title":"Stereotactic radiosurgery for vestibular schwannomas: tumor control probability analyses and recommended reporting standards","volume":"110","author":"Soltys","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2022.06.102","article-title":"Tumor control probability after radiosurgery of brain metastases with and without retreatment","volume":"114","author":"Sharma","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijrobp.2020.10.034","article-title":"Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases","volume":"110","author":"Redmond","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21037\/cco-21-146","article-title":"Optimal management of brainstem metastases: a narrative review","volume":"11","author":"Lee","year":"2022","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2217\/cns-2017-0029","article-title":"Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experience","volume":"7","author":"Patel","year":"2018","journal-title":"CNS Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijrobp.2020.11.021","article-title":"Stereotactic body radiation therapy for spinal metastases: tumor control probability analyses and recommended reporting standards","volume":"110","author":"Soltys","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109817","article-title":"Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses","volume":"187","author":"Wang","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-007-9458-4","article-title":"Gamma knife radiosurgery for brainstem metastases: the UCSF experience","volume":"86","author":"Kased","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2026.111449_b0190","doi-asserted-by":"crossref","unstructured":"Lorenzoni JG, Devriendt D, Massager N, et al. Brain stem metastases treated with radiosurgery: prognostic factors of survival and life expectancy estimation. Surg Neurol. 2009; 71 (2): 188-195; discussion 195, 195\u2013186.","DOI":"10.1016\/j.surneu.2008.01.029"},{"key":"10.1016\/j.radonc.2026.111449_b0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijrobp.2009.07.1750","article-title":"Stereotactic radiosurgery for single brainstem metastases: the cleveland clinic experience","volume":"78","author":"Koyfman","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0200","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11060-010-0514-0","article-title":"Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana-Farber\/Brigham and Women's Cancer Center experience","volume":"104","author":"Kelly","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2026.111449_b0205","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1227\/NEU.0b013e31821d31de","article-title":"Outcomes and prognostic factors for patients with brainstem metastases undergoing stereotactic radiosurgery","volume":"69","author":"Hatiboglu","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2026.111449_b0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2010.02.028","article-title":"Minimized doses for linear accelerator radiosurgery of brainstem metastasis","volume":"80","author":"Valery","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0215","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1227\/NEU.0b013e31823c40fe","article-title":"Accelerator-based stereotactic radiosurgery for brainstem metastases","volume":"70","author":"Lin","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2026.111449_b0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3171\/2012.7.GKS12977","article-title":"Gamma Knife surgery for patients with brainstem metastases","volume":"117","author":"Kawabe","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2026.111449_b0225","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1748-717X-7-107","article-title":"Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases","volume":"7","author":"Leeman","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11060-014-1373-x","article-title":"Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?","volume":"117","author":"Kilburn","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2026.111449_b0235","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11060-015-1927-6","article-title":"Brainstem metastases treated with stereotactic radiosurgery: safety, efficacy, and dose response","volume":"125","author":"Trifiletti","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2026.111449_b0240","first-page":"40","article-title":"Gamma knife stereotactic radiosurgery in the treatment of brainstem metastases: the MD Anderson experience","volume":"2","author":"Voong","year":"2015","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.radonc.2026.111449_b0245","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clineuro.2016.05.001","article-title":"Utility of graded prognostic assessment in evaluation of patients with brainstem metastases treated with radiosurgery","volume":"147","author":"Joshi","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.radonc.2026.111449_b0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13566-016-0281-4","article-title":"Radiosurgery for brainstem metastases with and without whole brain radiotherapy: clinical series and literature review","volume":"6","author":"Murray","year":"2017","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0255","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/jrr\/rrx042","article-title":"Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion: \u2018symptomatic control\u2019","volume":"58","author":"Nakamura","year":"2017","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2026.111449_b0260","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1016\/j.ijrobp.2018.07.1056","article-title":"Single fraction and fractionated radiosurgery for treatment of brainstem metastases","volume":"102","author":"Koffer","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0265","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13014-022-02111-5","article-title":"Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study","volume":"17","author":"Nicosia","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0270","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.4103\/jcrt.jcrt_426_21","article-title":"Fractionated stereotactic radiotherapy as a primary or salvage treatment for large brainstem metastasis","volume":"18","author":"Chatzikonstantinou","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.radonc.2026.111449_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107911","article-title":"Efficacy and safety of a \u201csandwich therapy\u201d based on staged stereotactic radiosurgery and bevacizumab for large brainstem metastases","volume":"233","author":"Wang","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.radonc.2026.111449_b0280","doi-asserted-by":"crossref","first-page":"e1158","DOI":"10.1016\/j.wneu.2023.04.085","article-title":"Brainstem Metastases Treated with Stereotactic Radiosurgery: Masked versus Framed Immobilization","volume":"175","author":"Begley","year":"2023","journal-title":"World Neurosurg"},{"key":"10.1016\/j.radonc.2026.111449_b0285","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10143-024-02369-1","article-title":"Outcomes of 2-SSRS plus bevacizumab therapy strategy for brainstem metastases (BSM) over 2 cm3: a multi-center study","volume":"47","author":"Wang","year":"2024","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.radonc.2026.111449_b0290","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ijc.34980","article-title":"Stereotactic radiosurgery and radiotherapy for brainstem metastases: an international multicenter analysis","volume":"155","author":"Ehret","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2026.111449_b0295","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jrr\/rrae057","article-title":"Multifraction stereotactic radiotherapy utilizing inhomogeneous dose distribution for brainstem metastases: a single-center retrospective analysis","volume":"65","author":"Ikawa","year":"2024","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2026.111449_b0300","article-title":"Fractionated stereotactic radiotherapy of brainstem metastases-Clinical outcome and prognostic factors","volume":"50","author":"Kr\u00e4mer","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11060-012-0912-6","article-title":"Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors","volume":"109","author":"Ogura","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2026.111449_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jrr\/rrad090","article-title":"Revolutionizing radiation therapy: the role of AI in clinical practice","volume":"65","author":"Kawamura","year":"2024","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2026.111449_b0320","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00701-003-0034-1","article-title":"Gamma knife radiosurgery for metastatic tumours in the brain stem","volume":"145","author":"Shuto","year":"2003","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.radonc.2026.111449_b0325","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/SMJ.0b013e318296d9fa","article-title":"Patient-centered approach to ensuring appropriateness of care through blood management","volume":"106","author":"King","year":"2013","journal-title":"South Med J"},{"key":"10.1016\/j.radonc.2026.111449_b0330","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/cancers16061093","article-title":"Stereotactic radiosurgery and stereotactic fractionated radiotherapy in the management of brain metastases","volume":"16","author":"Benkhaled","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2026.111449_b0335","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1227\/01.NEU.0000073546.61154.9A","article-title":"The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases","volume":"53","author":"Chang","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2026.111449_b0340","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2003.10.009","article-title":"Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy","volume":"59","author":"Shehata","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0345","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jjco\/hyt082","article-title":"Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma","volume":"43","author":"Morimoto","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0350","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.3390\/ijms15069748","article-title":"Gamma knife treatment of brainstem metastases","volume":"15","author":"Peterson","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111449_b0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13014-021-01766-w","article-title":"Dosimetric study between a single isocenter dynamic conformal arc therapy technique and Gamma Knife radiosurgery for multiple brain metastases treatment: impact of target volume geometrical characteristics","volume":"16","author":"Chea","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0360","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3389\/fonc.2020.00568","article-title":"Single-isocenter volumetric modulated arc therapy vs. cyberknife m6 for the stereotactic radiosurgery of multiple brain metastases","volume":"10","author":"El Shafie","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0365","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14404","article-title":"Dosimetric comparison of HyperArc and InCise MLC-based CyberKnife plans in treating single and multiple brain metastases","volume":"25","author":"Zhu","year":"2024","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0370","first-page":"323","article-title":"Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care","volume":"22","author":"Mansouri","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0375","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1016\/j.wneu.2018.07.263","article-title":"Toxicity of Radiosurgery for Brainstem Metastases","volume":"119","author":"Patel","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.radonc.2026.111449_b0380","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/neuonc\/noaa192","article-title":"Executive summary from American Radium Society's appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases","volume":"22","author":"Milano","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0385","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2016.08.039","article-title":"Association between radiation necrosis and tumor biology after stereotactic radiosurgery for brain metastasis","volume":"96","author":"Miller","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0390","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.ijrobp.2018.06.349","article-title":"Randomized phase III trial comparing gamma knife and linac based (EDGE) approaches for brain metastases radiosurgery: results from the gadget trial","volume":"102","author":"Navarria","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111449_b0395","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2020.03.024","article-title":"Linear accelerator-based radiosurgery is associated with lower incidence of radionecrosis compared with gamma knife for treatment of multiple brain metastases","volume":"147","author":"Sebastian","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0400","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.4347","article-title":"Symptomatic necrosis with dual immune-checkpoint inhibition and radiosurgery for brain metastases","volume":"8","author":"Vaios","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2026.111449_b0405","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamaoncol.2018.1660","article-title":"Estimation of the percentage of US patients with cancer who benefit from genome-driven oncology","volume":"4","author":"Marquart","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111449_b0410","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw Open"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:13:31Z","timestamp":1781122411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":82,"alternative-id":["S0167814026000885"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111449","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor control probability modeling of stereotactic radiosurgery and fractionated stereotactic radiosurgery for patients with brainstem metastases","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111449"}}